Literature DB >> 7542181

Differential phospholamban gene expression in murine cardiac compartments. Molecular and physiological analyses.

K L Koss1, S Ponniah, W K Jones, I L Grupp, E G Kranias.   

Abstract

Phospholamban, the regulator of the Ca2+ pump in cardiac sarcoplasmic reticulum, is differentially expressed between murine atrial and ventricular muscles. Quantitative analyses of RNA isolated from atrial flaps and ventricular apices indicated that the phospholamban gene transcript copy number is 2.5-fold higher in the ventricle compared with the atrium of the FVB/N mouse and 6-fold higher in the ventricle compared with the atrium of the B6D2/F1 mouse strain. These findings were corroborated by in situ hybridization studies of cardiopulmonary sections from both murine strains, and phospholamban transcripts were also observed in pulmonary myocardia of both strains. Analyses of phospholamban transcript levels relative to alpha-myosin heavy chain (alpha-MHC) revealed a 3-fold higher phospholamban abundance in the ventricle compared with the atrium of the FVB/N murine strain. However, the relative mRNA level of Ca(2+)-ATPase (ratio of sarcoplasmic reticulum Ca(2+)-ATPase [SERCA2] to alpha-MHC) in the ventricle was 80% of that in the atrium. Consequently, the relative ratio of phospholamban to SERCA2 mRNA was 4.2-fold lower in the atrium than in the ventricle. The lower transcript ratio of phospholamban to SERCA2 in the atrium was associated with significantly shortened times to half-relaxation (17.40 +/- 0.71 milliseconds for atrium versus 30.58 +/- 2.04 milliseconds for ventricle), assessed in isolated superfused cardiac tissue preparations recorded at maximum length tension. Contraction times, measured as times to peak tension, were also significantly shortened in atrial muscle (27.36 +/- 0.82 milliseconds) compared with ventricular muscle (44.60 +/- 2.55 milliseconds), assessed in the same tissue preparations. These findings suggest that phospholamban gene expression is differentially regulated in murine atrial and ventricular muscles and that this differential expression may be associated with differences in the contractile parameters of these cardiac compartments.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542181     DOI: 10.1161/01.res.77.2.342

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  18 in total

1.  Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding.

Authors:  D Sarsero; P Molenaar; A J Kaumann; N S Freestone
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Decreased expression of phospholamban is not associated with lower beta-adrenergic activation in rat atria.

Authors:  A Kaasik; K Paju; A Minajeva; J Ohisalo
Journal:  Mol Cell Biochem       Date:  2001-07       Impact factor: 3.396

3.  Sarcolipin and phospholamban mRNA and protein expression in cardiac and skeletal muscle of different species.

Authors:  Peter Vangheluwe; Marleen Schuermans; Ernö Zádor; Etienne Waelkens; Luc Raeymaekers; Frank Wuytack
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

4.  Thyroid hormones differentially affect sarcoplasmic reticulum function in rat atria and ventricles.

Authors:  A Kaasik; A Minajeva; K Paju; M Eimre; E K Seppet
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

5.  Differences in sarcoplasmic reticulum gene expression in myocardium from patients undergoing cardiac surgery. Quantification of steady-state levels of messenger RNA using the reverse transcription-polymerase chain reaction.

Authors:  T Ohkusa; T Noma; T Ueyama; Y Hisamatsu; M Yano; K Esato; A Nakazawa; M Matsuzaki
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

6.  Enhanced Ca2+ transport and muscle relaxation in skeletal muscle from sarcolipin-null mice.

Authors:  A Russell Tupling; Eric Bombardier; Subash C Gupta; Dawar Hussain; Chris Vigna; Darin Bloemberg; Joe Quadrilatero; Maria G Trivieri; Gopal J Babu; Peter H Backx; Muthu Periasamy; David H MacLennan; Anthony O Gramolini
Journal:  Am J Physiol Cell Physiol       Date:  2011-06-22       Impact factor: 4.249

7.  Pacing-induced calcineurin activation controls cardiac Ca2+ signalling and gene expression.

Authors:  Pasi Tavi; Sampsa Pikkarainen; Jarkko Ronkainen; Perttu Niemelä; Mika Ilves; Matti Weckström; Olli Vuolteenaho; Joseph Bruton; Håkan Westerblad; Heikki Ruskoaho
Journal:  J Physiol       Date:  2003-10-17       Impact factor: 5.182

8.  Threonine-5 at the N-terminus can modulate sarcolipin function in cardiac myocytes.

Authors:  Poornima Bhupathy; Gopal J Babu; Makoto Ito; Muthu Periasamy
Journal:  J Mol Cell Cardiol       Date:  2009-07-23       Impact factor: 5.000

9.  Identification of Small Ankyrin 1 as a Novel Sarco(endo)plasmic Reticulum Ca2+-ATPase 1 (SERCA1) Regulatory Protein in Skeletal Muscle.

Authors:  Patrick F Desmond; Joaquin Muriel; Michele L Markwardt; Mark A Rizzo; Robert J Bloch
Journal:  J Biol Chem       Date:  2015-09-24       Impact factor: 5.157

10.  Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.

Authors:  V J Kadambi; S Ponniah; J M Harrer; B D Hoit; G W Dorn; R A Walsh; E G Kranias
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.